Covered recipient · General Payments record
JENNIFER P STONE
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2023
$1,749.65
- Reported across 72 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $307.41 | 13 |
| Education | $19.81 | 1 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $67.45 | 3 |
| Merck Sharp & Dohme Corporation | $62.28 | 3 |
| Daiichi Sankyo Inc. | $55.87 | 2 |
| Amgen Inc. | $29.31 | 1 |
| GlaxoSmithKline, LLC. | $25.09 | 1 |
| Astellas Pharma US Inc | $24.00 | 1 |
| Gilead Sciences, Inc. | $23.34 | 1 |
| Pharmacyclics LLC, An AbbVie Company | $22.16 | 1 |
| TAIHO ONCOLOGY, INC. | $17.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $29.31 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020599443 | CMS |
| Astellas Pharma US Inc | $24.00 | 10/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034589793 | CMS |
| Daiichi Sankyo Inc. | $25.38 | 01/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006381503 | CMS |
| Daiichi Sankyo Inc. | $30.49 | 04/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006407239 | CMS |
| Gilead Sciences, Inc. | $23.34 | 02/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1025697471 | CMS |
| GlaxoSmithKline, LLC. | $25.09 | 03/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001650483 | CMS |
| Merck Sharp & Dohme LLC | $14.95 | 01/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1048619753 | CMS |
| Merck Sharp & Dohme LLC | $19.81 | 03/14/2023 | Education | Undisputed | 01/23/2026 | 1048619749 | CMS |
| Merck Sharp & Dohme LLC | $27.52 | 05/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1048834403 | CMS |
| PFIZER INC. | $21.34 | 03/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050677791 | CMS |
| PFIZER INC. | $24.77 | 05/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049517739 | CMS |
| PFIZER INC. | $21.34 | 05/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049202539 | CMS |
| Pharmacyclics LLC, An AbbVie Company | $22.16 | 06/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998296145 | CMS |
| TAIHO ONCOLOGY, INC. | $17.72 | 02/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1055230399 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.